rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Harold Bernstein

President, R&D & CMO

Company insider

Files Form 4 as: President, R&D & CMO, Maze Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
118
Buys
0
Sells
17
Bought
$0
Sold
$16.7M
Companies
1
Companies where not an officer
0
First trade
22 Sep 2025
Last trade
1 Oct 2026
Last filed
2 Oct 2026

Companies traded

Where they are an officer
MAZE Maze TherapeuticsOfficer · Biotechnology · last 1 Oct 20260 buys · 17 sells

Activity over time

1 Dec 2025 – 1 Oct 2026
50Dec 25Mar 26May 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 2 Oct 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Code M$168K16,141 at $10.42filing
1 Oct 2026filed 2 Oct 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$435K16,141 at $26.93filing
1 Oct 2026filed 2 Oct 2026MAZE Maze Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—16,141 at $0.00filing
4 Sep 2026filed 8 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$255K9,705 at $26.22filing
4 Sep 2026filed 8 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$254K9,705 at $26.22filing
3 Sep 2026filed 4 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$133K5,130 at $26.01filing
3 Sep 2026filed 4 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$1,52159 at $25.78filing
3 Sep 2026filed 4 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$133K5,130 at $26.01filing
3 Sep 2026filed 4 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$1,52159 at $25.78filing
2 Sep 2026filed 4 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$118K4,481 at $26.38filing
2 Sep 2026filed 4 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$17K625 at $27.12filing
2 Sep 2026filed 4 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$118K4,481 at $26.38filing
2 Sep 2026filed 4 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$17K625 at $27.12filing
1 Sep 2026filed 3 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Code M$168K16,141 at $10.42filing
1 Sep 2026filed 3 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Sold$426K16,141 at $26.36filing
1 Sep 2026filed 3 Sep 2026MAZE Maze TherapeuticsBiotechnologySEC FORM 4 Code M—20,000 at $0.00filing
1 Sep 2026filed 3 Sep 2026MAZE Maze Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—16,141 at $0.00filing
1 Sep 2026filed 3 Sep 2026MAZE Maze Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—20,000 at $0.00filing
1 Sep 2026filed 3 Sep 2026MAZE Maze Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—16,141 at $0.00filing
1 Sep 2026filed 3 Sep 2026MAZE Maze Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—20,000 at $0.00filing

Sectors

Health Care17

Buys in green, sells in red, by the company’s sector.

Related people

Jason Coloma VChief Executive Officer · Chief Executive Officer at Maze Therapeutics, filing Form 4 there in the last year
Atul DandekarCsbo · Csbo at Maze Therapeutics, filing Form 4 there in the last year
Phillips CourtneyGC and Corp. Secretary · GC and Corp. Secretary at Maze Therapeutics, filing Form 4 there in the last year
Paula A. JohnsonDirector · Director at Maze Therapeutics, filing Form 4 there in the last year
Sophie KornowskiDirector · Director at Maze Therapeutics, filing Form 4 there in the last year